To view this email as a web page, click here.
 
PHARMACISTS' REPORT
 
Generics and Biosimilars Facing Formulary Difficulties
image description here New changes are making it more idfficult for generics and biosimilars to compete on formularies.

More
 
FDA Grants Tepotinib Breakthrough Therapy Designation
image description here Investigational oral MET kinase inhibitor from Merck.

More
 
New Developments in Treating and Diagnosing COPD
image description here Imaging techniques, stem cell therapy, and more!

More
 
Read More
 
Training the Technicians
How Pharmacy Will Change in 2019
Five Tips for Surviving a 12-Hour Pharmacy Shift
When Shingles Gets in Your Eyes
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.